AI-generated summary
The authors report a randomized controlled trial of 31 adults with hypopigmented scars or striae alba treated with a 308-nm excimer laser, compared with untreated control lesions. Visual pigment correction averaged about 61% to 68% after nine treatments, and both measures declined toward baseline during six months of follow-up. No blistering or dyspigmentation was reported.
- Participants
- 31
- Who or what was studied
- Adults with hypopigmented scars or striae alba on the face, torso, or extremities
- Wavelengths
- 308 nm
- Limits stated in the abstract
- The abstract notes that treatment effects faded during follow-up, so maintenance treatment was needed, and the sample was a volunteer group at a single private research center.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on archderm.jamanetwork.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Randomized controlled trial, Confidence interval, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.